Literature DB >> 8535645

Possible mechanisms of action of methotrexate in patients with rheumatoid arthritis.

J M Kremer1.   

Abstract

Methotrexate has been reported to be effective in various animal models of arthritis as well as a variety of human disorders without a shared pathogenesis. Reports have emerged of the effect of the drug on lymphocytes, cytokines, leukotrienes, neutrophils, as well as a large variety of intracellular biochemical pathways. At present, it is not possible to identify which of the many possible mechanisms of action are relevant to its action when used in patients with rheumatoid arthritis (RA). More definitive insights may have to await a better understanding of the immunopathogenesis of RA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8535645

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  4 in total

1.  Neutrophil function in pregnancy and rheumatoid arthritis.

Authors:  I P Crocker; P N Baker; J Fletcher
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

2.  Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis.

Authors:  K Hildner; S Finotto; C Becker; J Schlaak; P Schirmacher; P R Galle; E Märker-Hermann; M F Neurath
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

3.  Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?

Authors:  L D Fairbanks; K Rückemann; Y Qiu; C M Hawrylowicz; D F Richards; R Swaminathan; B Kirschbaum; H A Simmonds
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

Review 4.  Use of methotrexate in juvenile idiopathic arthritis.

Authors:  A V Ramanan; P Whitworth; E M Baildam
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.